Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ETHZilla Corp | 66,888 | reported | 15 Dec 2023 | tx 6+1,553,500 |
| TETRALOGIC PHARMACEUTICALS CORP | 30,000 | reported | 28 Jan 2015 | tx 28+1,011,988−740,561 |
| OncoMed Pharmaceuticals Inc | 0 | reported | 23 Jul 2013 | tx 31+2,761,189−2,672,954 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Dec 2023 | PURCHASE | ETHZilla Corp | 25,000 | 0.19 USD | |
| 04 Sept 2023 | GRANT_AWARD | ETHZilla Corp | 75,000 | 0.00 USD | deriv |
| 18 May 2023 | PURCHASE | ETHZilla Corp | 40,000 | 1.03 USD | first after silence |
| 09 Dec 2021 | PURCHASE | ETHZilla Corp | 12,500 | 4.27 USD | first after silence |
| 26 Feb 2021 | GRANT_AWARD | ETHZilla Corp | 1,400,000 | 0.00 USD | deriv |
| 09 Nov 2020 | PURCHASE | ETHZilla Corp | 1,000 | 3.29 USD | first after silence |
| 28 Jan 2015 | GRANT_AWARD | TETRALOGIC PHARMACEUTICALS CORP | 10,000 | 5.25 USD | deriv |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 5,681 | — | |
| 17 Dec 2013 | EXERCISE | TETRALOGIC PHARMACEUTICALS CORP | 71 | 6.40 USD | |
| 17 Dec 2013 | EXERCISE | TETRALOGIC PHARMACEUTICALS CORP | 143 | 6.40 USD | |
| 17 Dec 2013 | EXERCISE | TETRALOGIC PHARMACEUTICALS CORP | 2,850 | 6.40 USD | |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 2,602 | 7.00 USD | |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 5,205 | 7.00 USD | |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 104,118 | 7.00 USD | |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 11,363 | — | |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 227,266 | — | |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 8,866 | — | |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 17,733 | — | |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 354,663 | — | |
| 17 Dec 2013 | PURCHASE | TETRALOGIC PHARMACEUTICALS CORP | 6,079 | 7.00 USD | |
| 17 Dec 2013 | PURCHASE | TETRALOGIC PHARMACEUTICALS CORP | 12,159 | 7.00 USD | |
| 17 Dec 2013 | PURCHASE | TETRALOGIC PHARMACEUTICALS CORP | 243,189 | 7.00 USD | |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 5,205 | — | deriv |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 2,602 | — | deriv |
| 17 Dec 2013 | EXERCISE | TETRALOGIC PHARMACEUTICALS CORP | 2,850 | — | deriv |
3 purchases reported after at least 12 months of silence — most recent on 18 May 2023.